Literature DB >> 29022109

Interaction of CD80 with Neph1: a potential mechanism of podocyte injury.

Bhavya Khullar1, Renu Balyan2, Neelam Oswal2, Nidhi Jain2, Amita Sharma1, Malik Z Abdin3, Arvind Bagga4, Shinjini Bhatnagar1, Nitya Wadhwa1, Uma Chandra Mouli Natchu1, Anna George2, Satyajit Rath1,2, Vineeta Bal1,2, Shailaja Sopory5.   

Abstract

BACKGROUND: The induction of CD80 on podocytes has been shown in animal models of podocyte injury and in certain cases of nephrotic syndrome. In a lipopolysaccharide (LPS)-induced mouse model of albuminuria, we have recently shown a signalling axis of LPS-myeloid cell activation-TNFα production-podocyte CD80 induction-albuminuria. Therefore, in this report, we investigated the cellular and molecular consequences of TNFα addition and CD80 expression on cultured podocytes.
METHODS: A murine podocyte cell line was used for TNFα treatment and for over-expressing CD80. Expression and localization of various podocyte proteins was analysed by reverse transcriptase-polymerase chain reaction, western blotting and immunofluorescence. HEK293 cells were used to biochemically characterize interactions.
RESULTS: Podocytes treated with LPS in vitro did not cause CD80 upregulation but TNFα treatment was associated with an increase in CD80 levels, actin derangement and poor wound healing. Podocytes stably expressing CD80 showed actin derangement and co-localization with Neph1. CD80 and Neph1 interaction was confirmed by pull down assays of CD80 and Neph1 transfected in HEK293 cells.
CONCLUSION: Addition of TNFα to podocytes causes CD80 upregulation, actin reorganization and podocyte injury. Overexpressed CD80 and Neph1 interact via their extracellular domain. This interaction implies a mechanism of slit diaphragm disruption and possible use of small molecules that disrupt CD80-Neph1 interaction as a potential for treatment of nephrotic syndrome associated with CD80 upregulation.

Entities:  

Keywords:  CD80; Lipopolysaccharide; Minimal change disease; Neph1; Podocytes; TNFα

Mesh:

Substances:

Year:  2017        PMID: 29022109     DOI: 10.1007/s10157-017-1489-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  36 in total

1.  c-mip impairs podocyte proximal signaling and induces heavy proteinuria.

Authors:  Shao-Yu Zhang; Maud Kamal; Karine Dahan; André Pawlak; Virginie Ory; Dominique Desvaux; Vincent Audard; Marina Candelier; Fatima BenMohamed; Fatima Ben Mohamed; Marie Matignon; Christo Christov; Xavier Decrouy; Veronique Bernard; Gilles Mangiapan; Philippe Lang; Georges Guellaën; Pierre Ronco; Djillali Sahali
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

2.  Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN.

Authors:  D B Donoviel; D D Freed; H Vogel; D G Potter; E Hawkins; J P Barrish; B N Mathur; C A Turner; R Geske; C A Montgomery; M Starbuck; M Brandt; A Gupta; R Ramirez-Solis; B P Zambrowicz; D R Powell
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

3.  Role of podocyte B7-1 in diabetic nephropathy.

Authors:  Paolo Fiorina; Andrea Vergani; Roberto Bassi; Monika A Niewczas; Mehmet M Altintas; Marcus G Pezzolesi; Francesca D'Addio; Melissa Chin; Sara Tezza; Moufida Ben Nasr; Deborah Mattinzoli; Masami Ikehata; Domenico Corradi; Valerie Schumacher; Lisa Buvall; Chih-Chuan Yu; Jer-Ming Chang; Stefano La Rosa; Giovanna Finzi; Anna Solini; Flavio Vincenti; Maria Pia Rastaldi; Jochen Reiser; Andrzej S Krolewski; Peter H Mundel; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

4.  Inhibition of type I interferon signalling prevents TLR ligand-mediated proteinuria.

Authors:  Sevgi Gurkan; Allison Cabinian; Victoria Lopez; Mantu Bhaumik; Jer-Ming Chang; Arnold B Rabson; Peter Mundel
Journal:  J Pathol       Date:  2013-10       Impact factor: 7.996

5.  Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.

Authors:  S Doublier; V Ruotsalainen; G Salvidio; E Lupia; L Biancone; P G Conaldi; P Reponen; K Tryggvason; G Camussi
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

6.  Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?

Authors:  David J Salant
Journal:  J Am Soc Nephrol       Date:  2015-09-23       Impact factor: 10.121

7.  Ischemic injury to kidney induces glomerular podocyte effacement and dissociation of slit diaphragm proteins Neph1 and ZO-1.

Authors:  Mark C Wagner; George Rhodes; Exing Wang; Vikas Pruthi; Ehtesham Arif; Moin A Saleem; Sarah E Wean; Puneet Garg; Rakesh Verma; Lawrence B Holzman; Vince Gattone; Bruce A Molitoris; Deepak Nihalani
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

8.  Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway.

Authors:  Michiko Shimada; Takuji Ishimoto; Pui Y Lee; Miguel A Lanaspa; Christopher J Rivard; Carlos A Roncal-Jimenez; David T Wymer; Hideaki Yamabe; Peter W Mathieson; Moin A Saleem; Eduardo H Garin; Richard J Johnson
Journal:  Nephrol Dial Transplant       Date:  2011-05-26       Impact factor: 5.992

9.  Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.

Authors:  Lionel C Clement; Carmen Avila-Casado; Camille Macé; Elizabeth Soria; Winston W Bakker; Sander Kersten; Sumant S Chugh
Journal:  Nat Med       Date:  2010-12-12       Impact factor: 53.440

10.  Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease.

Authors:  Eunsil Hahm; Changli Wei; Isabel Fernandez; Jing Li; Nicholas J Tardi; Melissa Tracy; Shikha Wadhwani; Yanxia Cao; Vasil Peev; Andrew Zloza; Jevgenijs Lusciks; Salim S Hayek; Christopher O'Connor; Markus Bitzer; Vineet Gupta; Sanja Sever; David B Sykes; David T Scadden; Jochen Reiser
Journal:  Nat Med       Date:  2016-12-12       Impact factor: 53.440

View more
  9 in total

1.  Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.

Authors:  Gabriel Cara-Fuentes; Miguel A Lanaspa; Gabriela E Garcia; Mindy Banks; Eduardo H Garin; Richard J Johnson
Journal:  Pediatr Nephrol       Date:  2018-03-01       Impact factor: 3.714

2.  B7-1 mediates podocyte injury and glomerulosclerosis through communication with Hsp90ab1-LRP5-β-catenin pathway.

Authors:  Jiemei Li; Jing Niu; Wenjian Min; Jun Ai; Xu Lin; Jinhua Miao; Shan Zhou; Ye Liang; Shuangqin Chen; Qian Ren; Kunyu Shen; Qinyu Wu; Xiaolong Li; Weiwei Shen; Fan Fan Hou; Youhua Liu; Peng Yang; Lili Zhou
Journal:  Cell Death Differ       Date:  2022-06-16       Impact factor: 15.828

Review 3.  Mechanisms of Podocyte Detachment, Podocyturia, and Risk of Progression of Glomerulopathies.

Authors:  Hernán Trimarchi
Journal:  Kidney Dis (Basel)       Date:  2020-05-27

4.  Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity.

Authors:  Anatilde M Gonzalez Guerrico; John Lieske; George Klee; Sanjay Kumar; Victor Lopez-Baez; Adam M Wright; Shane Bobart; Diane Shevell; Michael Maldonado; Jonathan P Troost; Marie C Hogan
Journal:  Kidney Int Rep       Date:  2020-08-14

Review 5.  CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease.

Authors:  Yoong Mond Teh; Soo Kun Lim; Norhana Jusoh; Kahar Osman; Siti Aisyah Mualif
Journal:  Biomed Res Int       Date:  2021-01-06       Impact factor: 3.411

Review 6.  Molecular Mechanisms of Proteinuria in Minimal Change Disease.

Authors:  Shrey Purohit; Federica Piani; Flor A Ordoñez; Carmen de Lucas-Collantes; Colin Bauer; Gabriel Cara-Fuentes
Journal:  Front Med (Lausanne)       Date:  2021-12-23

Review 7.  New Insights into the Treatment of Glomerular Diseases: When Mechanisms Become Vivid.

Authors:  Da-Wei Lin; Cheng-Chih Chang; Yung-Chien Hsu; Chun-Liang Lin
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 8.  Biomarkers in pediatric glomerulonephritis and nephrotic syndrome.

Authors:  Gabriel Cara-Fuentes; William E Smoyer
Journal:  Pediatr Nephrol       Date:  2021-01-03       Impact factor: 3.714

9.  Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis.

Authors:  Rhea Bhargava; Sylvain Lehoux; Kayaho Maeda; Maria G Tsokos; Suzanne Krishfield; Lena Ellezian; Martin Pollak; Isaac E Stillman; Richard D Cummings; George C Tsokos
Journal:  JCI Insight       Date:  2021-05-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.